The world's largest hearing implant maker Cochlear Limited (COH) has missed market expectations with its first half profit, due to the staggered launch of its...

The world's largest hearing implant maker Cochlear Limited (COH) has missed market expectations with its first half profit, due to the staggered launch of its newest device, which had been seen as a key stepping stone in rebuilding the company's profit and reputation. Profit for the six months to December 31 2013 came in at $21 million, down 73% from the prior corresponding period and well below expectations. Total revenue fell 5% to $371 million while earnings fell 54% to $49 million. COH's latest device, the Nucleus 6, which allows users to connect wirelessly to smartphones, received regulatory approval in Europe and the US last year, however not all of the product's features were approved impacting the release of the device in key markets. Summary of results available here: (VIEW LINK) @jsaly @commsec


2 topics

The Livewire Equities feed brings you a range of insights that relate to Australian equities

Expertise

No areas of expertise

I would like to

Only to be used for sending genuine email enquiries to the Contributor. Livewire Markets Pty Ltd reserves its right to take any legal or other appropriate action in relation to misuse of this service.

Personal Information Collection Statement
Your personal information will be passed to the Contributor and/or its authorised service provider to assist the Contributor to contact you about your investment enquiry. They are required not to use your information for any other purpose. Our privacy policy explains how we store personal information and how you may access, correct or complain about the handling of personal information.